This inventor holds 4 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignee: Step Pharma S.a.s.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Abdul Quddus
Introduction
Abdul Quddus is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific biological targets. With a total of three patents to his name, his work is recognized for its potential impact on medical science.
Latest Patents
Abdul Quddus's latest patents include innovative compounds such as aminopyrimidine/pyrazine derivatives that act as CTPS1 inhibitors. These compounds, described in detail in his patents, are formulated to address specific biochemical pathways, showcasing his expertise in medicinal chemistry.
Career Highlights
Throughout his career, Abdul Quddus has been associated with Step Pharma S.a.s., where he has played a crucial role in advancing research and development initiatives. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the pharmaceutical industry.
Collaborations
Abdul Quddus has collaborated with talented individuals such as Emma Blackham and Andrew Richard Novak. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Abdul Quddus exemplifies the spirit of innovation in the pharmaceutical sector through his patents and collaborations. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile